space
space

Get in Touch

spacer(91)-20-30242014
Friday
Mar 06, 2015
subscribe
You are here article details
 

US FDA’s Alert On Wockhardt: Much Ado About Nothing?

| 5/30/2013 9:02 PM Thursday

Pharma giant Wockhardt has received a strong setback after the US FDA sounded an alert on its Waluj manufacturing facility, after which the stock was hammered by more than 25 per cent in just two trading sessions. The market, however, seems to be overreacting to these developments. Shrikant Akolkar tells us more.

One of the worst things to happen to any stock is for it to get hit by factors which are apparently serious but on deeper exploration seem to be routine. This happens chiefly due to investors’ knee-jerk reaction to news flows which creates humongous negativity around it. One company which has recently been hit by this syndrome is Wockhardt.

We had recommended Wockhardt in DSIJ Vol. 28, Issue # 9 (dated 21 April, 2013) in our cover story ‘Cherry Picking’. The scrip was severely hammered following the recent US FDA alert on its manufacturing facility located in Waluj, Aurangabad district of Maharashtra. In just two trading sessions alone (May 23 and 24, 2013) it lost more than 25 per cent in value. Currently, the stock is down 35 per cent from where we had recommended it. Investors who have acted on our advice would surely be jittery in the wake of such a slide in the stock’s price. What should their future course in this counter be? Should one sell and book losses or wait out the depression? Here are the answers that you would be looking out for.

To start with, the hammering of the stock was a knee-jerk reaction arising out of fears fuelled by a particular event. This fear was accentuated by many other factors that were external to the company. The principal factor among these was the developments in Ranbaxy earlier in the same week.

Ranbaxy, the pharma company now owned by Daichhi Sankyo, pleaded guilty before the United States Department of Justice on compliance related issues in two of its manufacturing facilities. This was in any case weighing heavily on pharma stocks. The alert on Wockhardt’s Waluj facility came immediately after this, and dampened the sentiment on the stock.

What is worth noting is that Ranbaxy had ignored earlier malpractices, the consequences of which it had to bear. Wockhardt, however, had invited the US FDA team to audit its new injectables unit at Waluj. This is what differentiates between the two companies.

Find More Articles on: DSIJ Magazine, Special Report, Stock Recommendations, Fundamental Picks, Product, Large Cap

«« First « Previous |1 2 | Last ››

Related Readings

Top 10 companies with Lowest Foreign Institutional Investors (FIIs) Holding in BSE 100 Companies

DSIJ.in Exclusive

LatestMost PopularMarket Action

Breaking News

Sun Pharma to buy Glaxo's opiates business in Australia

Sun Pharmaceutical Industries has agreed to buy Glaxo Smith Kline' s opiates business in Australia to strengthen its pain management portfolio. The business consists of analgesics made from raw materials found in opium poppy plants, and includes two manufacturing sites in the states of Tasmania and Victoria. The firms did not disclose the financial details of the deal but it is expected to be closed by August.

Miscellany: Key Highlights of Budget 2015: relating to Direct Taxes

JayeshDadia- Chartered Accountant, Key Highlights of Budget 2015- relating to Direct Taxes

Major Influencers of the U.S. Dollar Index

The U.S. Dollar, as a currency, holds a lot of importance and relevance when it comes to Foreign Exchange. It is one such currency that it practically used for all international transactions. That is the reason why it is known as a Global currency.

Naveen Mathur, Associate Director - Commodities & Currencies, Angel Broking explains the factors that impact this currency

Kerbside

The recommendations provided in this column are taken from different market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Dalal Street Investment Journal may or may not subscribe to these recommendations.

Union Budget 2015 - What’s In It For You?

It’s a budget of hits and misses but does have the potential to pave the way for economic growth, By Hemant Rustagi
CEO, Wiseinvest Advisors 

Indices Flattish, Ends On Positive Mark.

The Indian markets saw some sluggish momentum in today’s session. The Healthcare index continues to make a gradual progress and surges more than 400 points. Some Banking and Auto stock also recovered well, up around 100 points each. Mid-caps and Small-Caps closed in green territory. The Nifty index closed up by 15 points at 8937, while Sensex was up by 68 points at 29448.

STYLES OF INVESTING

An investment isn’t just the means to park your funds in a stock or any such asset class and then sit back and watch it grow. There are several methodologies that come into play and these are known as investment styles in accordance with the theories they are based on. This article sheds light on some of the popular approaches used by investors for both long and short-term gains

Special Report: 2015 The Year of IPOs

Indian equities are making new highs in almost every month and an optimistic picture can be seen in the Indian stock markets since 2014 Lok Sabha elections. Considering the way the governmnet started implementing the reforms in the country, 2015 will be an action packed year from point of view of the primary capital markets. Article by Vivek Paratne

Stock Recommendations For Your Portfolio

The scrips in this column have been recommended with a short-term investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.

Stock Pick from Financial Institutions

Low Priced Scrip is hidden gem, today's underdog, a stock with future potential that is expected to fetch returns within one year. This is a stock picked carefully based on a fundamental analysis of the company. The company recommended as the Low Priced Scrip for this issue is an emerging player in Financial Institutions.

DSIJ Breakfast News

Start your day with DSIJ Breakfast Roundup, wind up with DSIJ Market Roundup. Register now to get the day’s market outlook, global cues, economic trends, top corporate news delivered straight to your inbox.

mail to

Start your day with DSIJ Breakfast Roundup, wind up with DSIJ Market Roundup. Register now to get the day’s market outlook, global cues, economic trends, top corporate news delivered straight to your inbox.

mail to  *
 *
 *
 *
 *
 *
Content

WE VALUE YOUR FEEDBACK

(* No Research/Stock Queries)
Name :
Email ID :
Cell Number :
Message :